XML 142 R135.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Net financial results (Details) - BRL (R$)
R$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Financial expenses [Abstract]        
Interest on loans, financing and debentures (1)     R$ (1,743,417) R$ (1,797,937)
Amortization of transaction costs (2)     (39,616) (32,421)
Interest expenses on lease liabilities (3)     (222,185) (223,237)
Other     (278,075) (254,471)
Financial expenses     (2,283,293) (2,308,066)
Financial income [Abstract]        
Cash and cash equivalents and marketable securities     819,082 683,608
Other     62,023 106,290
Financial income     881,105 789,898
Results from derivative financial instruments [Abstract]        
Income     824,285 6,758,955
Expenses     (5,349,163) (1,859,936)
Results from derivative financial instruments R$ (3,890,341) R$ 2,903,766 (4,524,878) 4,899,019
Monetary and exchange rate variations, net [Abstract]        
Exchange rate variations on loans, financing and debentures     (9,383,027) 4,543,048
Leases     (329,505) 191,986
Other assets and liabilities (4)     1,525,875 (1,110,099)
Monetary and exchange rate variations, net R$ (6,487,329) R$ 2,376,817 (8,186,657) 3,624,935
Net financial result     (14,113,723) 7,005,786
Interest costs capitalised     802,515 511,650
Transaction Costs for Loans and Financing       19
Reclassification to biological assets     R$ 104,137 R$ 49,946